Which has better earnings and valuation, AMWL or HSTM?

HealthStream has higher revenue and earnings than American Well. American Well is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Well $249.32M 0.88 -$95.70M -$4.77 N/A HealthStream $304.06M 2.79 $18.34M $0.72 40.36

Does the media prefer AMWL or HSTM?

In the previous week, HealthStream had 5 more articles in the media than American Well. MarketBeat recorded 7 mentions for HealthStream and 2 mentions for American Well. American Well's average media sentiment score of 0.54 beat HealthStream's score of 0.32 indicating that American Well is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Well 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthStream 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer SOPH or AMWL?

In the previous week, SOPHiA GENETICS had 3 more articles in the media than American Well. MarketBeat recorded 5 mentions for SOPHiA GENETICS and 2 mentions for American Well. American Well's average media sentiment score of 0.54 beat SOPHiA GENETICS's score of 0.51 indicating that American Well is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SOPHiA GENETICS 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive American Well 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, PHR or AMWL?

Phreesia has higher revenue and earnings than American Well. American Well is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Phreesia $480.59M 1.29 $2.31M $0.17 58.94 American Well $249.32M 0.88 -$95.70M -$4.77 N/A

Is PHR or AMWL more profitable?

Phreesia has a net margin of 2.06% compared to American Well's net margin of -35.75%. Phreesia's return on equity of 5.22% beat American Well's return on equity. Company Net Margins Return on Equity Return on Assets Phreesia 2.06% 5.22% 3.02% American Well -35.75% -30.12% -22.30%

Does the media favor PHR or AMWL?

In the previous week, American Well had 1 more articles in the media than Phreesia. MarketBeat recorded 2 mentions for American Well and 1 mentions for Phreesia. Phreesia's average media sentiment score of 0.76 beat American Well's score of 0.54 indicating that Phreesia is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive American Well 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, AMWL or CTEV?

American Well has higher earnings, but lower revenue than Claritev. American Well is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Well $249.32M 0.88 -$95.70M -$4.77 N/A Claritev $965.41M 0.52 -$284.28M -$17.01 N/A

Is AMWL or CTEV more profitable?

Claritev has a net margin of -28.46% compared to American Well's net margin of -35.75%. Claritev's return on equity of 0.00% beat American Well's return on equity. Company Net Margins Return on Equity Return on Assets American Well -35.75% -30.12% -22.30% Claritev -28.46% N/A -5.76%

Does the media refer more to AMWL or CTEV?

In the previous week, Claritev had 4 more articles in the media than American Well. MarketBeat recorded 6 mentions for Claritev and 2 mentions for American Well. American Well's average media sentiment score of 0.54 beat Claritev's score of 0.37 indicating that American Well is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Well 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Claritev 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AMWL or MDRX?

American Well currently has a consensus target price of $9.50, indicating a potential downside of 28.57%. Given American Well's stronger consensus rating and higher possible upside, equities analysts plainly believe American Well is more favorable than Veradigm. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Well 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Veradigm 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings & valuation, AMWL or MDRX?

Veradigm has higher revenue and earnings than American Well. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Well $249.32M 0.88 -$95.70M -$4.77 N/A Veradigm $1.53B 0.39 N/A N/A N/A

American Well (AMWL) Competitors

$13.30 -0.12 (-0.89%)

As of 11:45 AM Eastern

Compare

AMWL vs. HSTM, SOPH, PHR, CTEV, and MDRX

Should you buy American Well stock or one of its competitors? American Well's main competitors and comparable companies include HealthStream (HSTM), SOPHiA GENETICS (SOPH), Phreesia (PHR), Claritev (CTEV), and Veradigm (MDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does American Well compare to HealthStream?

American Well (NYSE:AMWL) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

HealthStream has higher revenue and earnings than American Well. American Well is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.88	-$95.70M	-$4.77	N/A
HealthStream	$304.06M	2.79	$18.34M	$0.72	40.36

American Well has a beta of 1.71, indicating that its share price is 71% more volatile than the broader market. Comparatively, HealthStream has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

American Well presently has a consensus price target of $9.50, suggesting a potential downside of 28.57%. HealthStream has a consensus price target of $27.00, suggesting a potential downside of 7.09%. Given HealthStream's higher probable upside, analysts clearly believe HealthStream is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

56.1% of American Well shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 12.8% of American Well shares are held by insiders. Comparatively, 20.4% of HealthStream shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

HealthStream has a net margin of 6.60% compared to American Well's net margin of -35.75%. HealthStream's return on equity of 6.81% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
HealthStream	6.60%	6.81%	4.64%

In the previous week, HealthStream had 5 more articles in the media than American Well. MarketBeat recorded 7 mentions for HealthStream and 2 mentions for American Well. American Well's average media sentiment score of 0.54 beat HealthStream's score of 0.32 indicating that American Well is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Well	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

HealthStream beats American Well on 12 of the 15 factors compared between the two stocks.

How does American Well compare to SOPHiA GENETICS?

SOPHiA GENETICS (NASDAQ:SOPH) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

SOPHiA GENETICS presently has a consensus price target of $10.00, suggesting a potential upside of 20.85%. American Well has a consensus price target of $9.50, suggesting a potential downside of 28.57%. Given SOPHiA GENETICS's stronger consensus rating and higher probable upside, research analysts plainly believe SOPHiA GENETICS is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SOPHiA GENETICS	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

31.6% of SOPHiA GENETICS shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 4.9% of SOPHiA GENETICS shares are owned by insiders. Comparatively, 12.8% of American Well shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, SOPHiA GENETICS had 3 more articles in the media than American Well. MarketBeat recorded 5 mentions for SOPHiA GENETICS and 2 mentions for American Well. American Well's average media sentiment score of 0.54 beat SOPHiA GENETICS's score of 0.51 indicating that American Well is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SOPHiA GENETICS	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
American Well	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

American Well has a net margin of -35.75% compared to SOPHiA GENETICS's net margin of -93.86%. American Well's return on equity of -30.12% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%
American Well	-35.75%	-30.12%	-22.30%

SOPHiA GENETICS has higher earnings, but lower revenue than American Well. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SOPHiA GENETICS	$77.27M	8.98	-$79M	-$1.15	N/A
American Well	$249.32M	0.88	-$95.70M	-$4.77	N/A

SOPHiA GENETICS has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market. Comparatively, American Well has a beta of 1.71, indicating that its stock price is 71% more volatile than the broader market.

Summary

American Well beats SOPHiA GENETICS on 9 of the 16 factors compared between the two stocks.

How does American Well compare to Phreesia?

Phreesia (NYSE:PHR) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 5.2% of Phreesia shares are owned by company insiders. Comparatively, 12.8% of American Well shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Phreesia presently has a consensus target price of $14.00, suggesting a potential upside of 39.72%. American Well has a consensus target price of $9.50, suggesting a potential downside of 28.57%. Given Phreesia's stronger consensus rating and higher probable upside, equities analysts plainly believe Phreesia is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	10 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.37
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Phreesia has higher revenue and earnings than American Well. American Well is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.29	$2.31M	$0.17	58.94
American Well	$249.32M	0.88	-$95.70M	-$4.77	N/A

In the previous week, American Well had 1 more articles in the media than Phreesia. MarketBeat recorded 2 mentions for American Well and 1 mentions for Phreesia. Phreesia's average media sentiment score of 0.76 beat American Well's score of 0.54 indicating that Phreesia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
American Well	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Phreesia has a net margin of 2.06% compared to American Well's net margin of -35.75%. Phreesia's return on equity of 5.22% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	2.06%	5.22%	3.02%
American Well	-35.75%	-30.12%	-22.30%

Phreesia has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, American Well has a beta of 1.71, indicating that its stock price is 71% more volatile than the broader market.

Summary

Phreesia beats American Well on 13 of the 16 factors compared between the two stocks.

How does American Well compare to Claritev?

American Well (NYSE:AMWL) and Claritev (NYSE:CTEV) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

56.1% of American Well shares are held by institutional investors. Comparatively, 87.2% of Claritev shares are held by institutional investors. 12.8% of American Well shares are held by insiders. Comparatively, 7.4% of Claritev shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

American Well has higher earnings, but lower revenue than Claritev. American Well is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.88	-$95.70M	-$4.77	N/A
Claritev	$965.41M	0.52	-$284.28M	-$17.01	N/A

American Well currently has a consensus target price of $9.50, indicating a potential downside of 28.57%. Claritev has a consensus target price of $44.83, indicating a potential upside of 50.35%. Given Claritev's stronger consensus rating and higher possible upside, analysts plainly believe Claritev is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Claritev	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

In the previous week, Claritev had 4 more articles in the media than American Well. MarketBeat recorded 6 mentions for Claritev and 2 mentions for American Well. American Well's average media sentiment score of 0.54 beat Claritev's score of 0.37 indicating that American Well is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Well	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Claritev	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

American Well has a beta of 1.71, indicating that its stock price is 71% more volatile than the broader market. Comparatively, Claritev has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market.

Claritev has a net margin of -28.46% compared to American Well's net margin of -35.75%. Claritev's return on equity of 0.00% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
Claritev	-28.46%	N/A	-5.76%

Summary

Claritev beats American Well on 10 of the 16 factors compared between the two stocks.

How does American Well compare to Veradigm?

American Well (NYSE:AMWL) and Veradigm (NASDAQ:MDRX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

American Well has a beta of 1.71, indicating that its share price is 71% more volatile than the broader market. Comparatively, Veradigm has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market.

In the previous week, American Well had 2 more articles in the media than Veradigm. MarketBeat recorded 2 mentions for American Well and 0 mentions for Veradigm. American Well's average media sentiment score of 0.54 beat Veradigm's score of 0.00 indicating that American Well is being referred to more favorably in the media.

Company	Overall Sentiment
American Well	Positive
Veradigm	Neutral

Veradigm has a net margin of 0.00% compared to American Well's net margin of -35.75%. Veradigm's return on equity of 0.00% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
Veradigm	N/A	N/A	N/A

56.1% of American Well shares are owned by institutional investors. 12.8% of American Well shares are owned by company insiders. Comparatively, 2.3% of Veradigm shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

American Well currently has a consensus target price of $9.50, indicating a potential downside of 28.57%. Given American Well's stronger consensus rating and higher possible upside, equities analysts plainly believe American Well is more favorable than Veradigm.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Veradigm	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Veradigm has higher revenue and earnings than American Well.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.88	-$95.70M	-$4.77	N/A
Veradigm	$1.53B	0.39	N/A	N/A	N/A

Summary

American Well beats Veradigm on 9 of the 14 factors compared between the two stocks.

Get American Well News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMWL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMWL vs. The Competition

Export

Metric	American Well	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$220.12M	$1.72B	$7.29B	$23.03B
Dividend Yield	N/A	3.90%	2.53%	3.62%
P/E Ratio	-2.79	21.01	275.53	28.34
Price / Sales	0.88	90.21	688.53	20.84
Price / Cash	N/A	31.60	28.04	19.33
Price / Book	0.89	6.23	10.61	4.73
Net Income	-$95.70M	-$18.66M	$3.49B	$1.07B
7 Day Performance	-3.06%	0.98%	1.56%	-0.23%
1 Month Performance	12.33%	2.40%	-2.08%	-3.60%
1 Year Performance	105.25%	-16.27%	17.56%	8.23%

American Well Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMWL American Well	2.3041 of 5 stars	$13.30 -0.9%	$9.50 -28.6%	+107.1%	$220.12M	$249.32M	N/A	562
HSTM HealthStream	2.6364 of 5 stars	$29.81 +0.6%	$27.00 -9.4%	+0.3%	$870.90M	$321.12M	41.40	1,160
SOPH SOPHiA GENETICS	2.674 of 5 stars	$7.92 +0.8%	$10.00 +26.3%	+148.2%	$664.45M	$86.17M	N/A	415
PHR Phreesia	4.468 of 5 stars	$10.44 +0.2%	$14.00 +34.1%	-57.9%	$646.96M	$480.59M	61.32	1,789	Gap Up
CTEV Claritev	3.3729 of 5 stars	$35.39 -2.9%	$44.83 +26.7%	-39.0%	$599.75M	$994.67M	N/A	3,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AMWL) was last updated on 9/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

American Well (AMWL) Competitors

AMWL vs. HSTM, SOPH, PHR, CTEV, and MDRX

How does American Well compare to HealthStream?

Summary

How does American Well compare to SOPHiA GENETICS?

Summary

How does American Well compare to Phreesia?

Summary

How does American Well compare to Claritev?

Summary

How does American Well compare to Veradigm?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMWL vs. The Competition

American Well Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

American Well (AMWL) Competitors

AMWL vs. HSTM, SOPH, PHR, CTEV, and MDRX

How does American Well compare to HealthStream?

Which has better earnings and valuation, AMWL or HSTM?

Which has more risk and volatility, AMWL or HSTM?

Do analysts rate AMWL or HSTM?

Do institutionals & insiders believe in AMWL or HSTM?

Is AMWL or HSTM more profitable?

Does the media prefer AMWL or HSTM?

Summary

How does American Well compare to SOPHiA GENETICS?

Do analysts recommend SOPH or AMWL?

Do insiders and institutionals hold more shares of SOPH or AMWL?

Does the media prefer SOPH or AMWL?

Is SOPH or AMWL more profitable?

Which has preferable valuation & earnings, SOPH or AMWL?

Which has more risk & volatility, SOPH or AMWL?

Summary

How does American Well compare to Phreesia?

Do institutionals & insiders hold more shares of PHR or AMWL?

Do analysts recommend PHR or AMWL?

Which has preferable valuation & earnings, PHR or AMWL?

Does the media favor PHR or AMWL?

Is PHR or AMWL more profitable?

Which has more risk & volatility, PHR or AMWL?

Summary

How does American Well compare to Claritev?

Do insiders and institutionals believe in AMWL or CTEV?

Which has higher valuation & earnings, AMWL or CTEV?

Do analysts rate AMWL or CTEV?

Does the media refer more to AMWL or CTEV?

Which has more risk & volatility, AMWL or CTEV?

Is AMWL or CTEV more profitable?

Summary

How does American Well compare to Veradigm?

Which has more volatility and risk, AMWL or MDRX?

Does the media prefer AMWL or MDRX?

Is AMWL or MDRX more profitable?

Do institutionals and insiders believe in AMWL or MDRX?

Do analysts recommend AMWL or MDRX?

Which has stronger earnings & valuation, AMWL or MDRX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMWL vs. The Competition

American Well Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools